MVM Life Science Partners has provided drug discovery company Heptares Therapuetics with a further round of seed funding. MVM backed the establishment of Heptares, a spinout from the Medical Research Council, in 2007.
Software developer, which works on an AI-backed optical character recognition program, is opening a US-based subsidiary
GP plans to form a new care home group with six further facilities bought from Convico
Pantheon offers regional primary fund programmes, secondaries, and co-investment
Portobello Structured Partnership I will target minority stakes in mid-market companies